
Sign up to save your podcasts
Or


On this week’s Tech Nation, Moira speaks with Dr. Emily Falk, Professor of Communications, Psychology, and Marketing at the University of Pennsylvania, about her new book, "What We Value... The Neuroscience of Choice and Change."
Then, Jeff Liter, Founder and CEO of Luminary Therapeutics, shares how new developments in cell therapy could make treatments for cancer and autoimmune diseases more affordable and accessible, without needing to be personalized for each patient.
By Tech Nation4.4
6060 ratings
On this week’s Tech Nation, Moira speaks with Dr. Emily Falk, Professor of Communications, Psychology, and Marketing at the University of Pennsylvania, about her new book, "What We Value... The Neuroscience of Choice and Change."
Then, Jeff Liter, Founder and CEO of Luminary Therapeutics, shares how new developments in cell therapy could make treatments for cancer and autoimmune diseases more affordable and accessible, without needing to be personalized for each patient.

22,024 Listeners

43,971 Listeners

32,156 Listeners

38,515 Listeners

6,744 Listeners

43,778 Listeners

27,206 Listeners

2,866 Listeners

9,177 Listeners

465 Listeners

723 Listeners

924 Listeners

6,352 Listeners

931 Listeners

32 Listeners